Latham & Watkins represented Amgen in the offerings.Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes offerings…
Amgen’s $4 Billion Senior Unsecured Notes Offerings


Latham & Watkins represented Amgen in the offerings.Amgen Inc., one of the world’s leading biotechnology companies, priced on February 17, 2022, a senior unsecured notes offerings…
…